Rheumatology Oxford Journal
Fecha de publicación: 03 July 2018
Autores: Clément Lahaye, Zuzana Tatar, Jean-Jacques Dubost, Anne Tournadre, Martin Soubrier.
Background: The number of elderly people with chronic inflammatory rheumatic diseases is increasing. This heterogeneous and comorbid population is at particular risk of cardiovascular, neoplastic, infectious and iatrogenic complications. The development of biotherapies has paved the way for innovative therapeutic strategies, which are associated with toxicities.